Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists-Reference-Cited by-同舟云学术

Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists

Published:2016-06-21 Issue:28 Volume:7 Page:42919-42942
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Manrique Soraya Zorro¹,Dominguez Ana L.¹,Mirza Noweeda¹,Spencer Christopher D.¹,Bradley Judy M.¹,Finke James H.²,Lee James J.³⁴,Pease Larry R.¹,Gendler Sandra J.¹³⁵,Cohen Peter A.¹⁵

Affiliation:

1. Department of Immunology, Mayo Clinic in Arizona, Scottsdale, AZ, USA

2. Department of Immunology, Lerner Research Institute, Cleveland, OH, USA

3. Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, AZ, USA

4. Division of Pulmonary Medicine, Mayo Clinic in Arizona, Scottsdale, AZ, USA

5. Division of Hematology/Oncology, Mayo Clinic in Arizona, Scottsdale, AZ, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenic chemotherapy: great potential for improving response rates;Frontiers in Oncology;2023-12-06

2. The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy;Pharmaceutics;2022-06-10

3. Theoretical premises of a “three in one” therapeutic approach to treat immunogenic and nonimmunogenic cancers: a narrative review;Translational Cancer Research;2021-11

4. Experimental Comparison of the In Vivo Efficacy of Two Novel Anticancer Therapies;Anticancer Research;2021-07

5. Immune Modulator and Low-Temperature PTT-Induced Synergistic Immunotherapy for Cancer Treatment;ACS Applied Bio Materials;2021-01-22